Evidence map›Paper›PMID 36732082›Full record

ArticleClinical and translational medicine2023

A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy.

Jing Yang, Wei Zhang, Lin Jia, Fei Shi, Min Cao, Jichao Sun, Chengchao Xu, Zhijie Li, Zhiqiang Cheng, Shan-Chao Zhao and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Advances in Nanodynamic Therapy for Cancer Treatment.Nanomaterials (Basel, Switzerland) · 2024
    Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Jing YangDepartment of Nephrology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
Wei ZhangDepartment of Nephrology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
Lin JiaCollege of Pharmacy, Shenzhen Technology University, Shenzhen, China.
Fei ShiEmergency Department, Institute of Shenzhen Respiratory Diseases, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
Min CaoDepartment of Nephrology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
Jichao SunDepartment of Nephrology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
Chengchao XuDepartment of Nephrology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
Zhijie LiDepartment of Nephrology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
Zhiqiang ChengDepartment of Pathology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
Shan-Chao ZhaoDepartment of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
Jigang WangDepartment of Nephrology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.ORCID 0000-0002-0575-0105
Chuanbin YangDepartment of Nephrology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.ORCID 0000-0001-8288-4038

Funding

China Postdoctoral Science Foundation 2020M683182Guangdong Basic and Applied Basic Research Foundation 2020A1515110549National Key Research and Development Program of China 2020YFA0908000National Natural Science Foundation of China 81841001National Natural Science Foundation of China 81902787National Natural Science Foundation of China 82003721National Natural Science Foundation of China 82074098National Natural Science Foundation of China 82274182Shenzhen Science and Technology Innovation Commission JCYJ20210324114014039Shenzhen Science and Technology Innovation Commission JCYJ20210324115800001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GinsenosidesAutophagyginsenoside Rh2Ginsenosides

Identifiers

PMID36732082
PMCPMC9894730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.